Found: 87
Select item for more details and to access through your institution.
Prophylaxis with Tixagevimab/Cilgavimab in chronic lymphocytic leukaemia, a case control study.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Low Cell Bioenergetic Metabolism Characterizes Chronic Lymphocytic Leukemia Patients with Unfavorable Genetic Factors and with a Better Response to BTK Inhibition.
- Published in:
- Current Issues in Molecular Biology, 2024, v. 46, n. 6, p. 5085, doi. 10.3390/cimb46060305
- By:
- Publication type:
- Article
Persistence of monoclonal B‐cell expansion and intraclonal diversification despite virus eradication in patients affected by hepatitis C virus‐associated lymphoproliferative disorders.
- Published in:
- British Journal of Haematology, 2023, v. 203, n. 2, p. 237, doi. 10.1111/bjh.19002
- By:
- Publication type:
- Article
COVID‐19 vaccination: Evaluation of humoral and cellular immunity after the booster dose in chronic lymphocytic leukemia patients.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 3, p. 559, doi. 10.1002/hon.3121
- By:
- Publication type:
- Article
Loss of CDKN1B induces an age‐related clonal hematopoietic disorder via Notch2 activity dysregulation.
- Published in:
- Cancer Communications, 2023, v. 43, n. 7, p. 844, doi. 10.1002/cac2.12444
- By:
- Publication type:
- Article
Targeted chitosan nanobubbles as a strategy to down-regulate microRNA-17 into B-cell lymphoma models.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1200310
- By:
- Publication type:
- Article
Measurable residual disease in chronic lymphocytic leukemia.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1112616
- By:
- Publication type:
- Article
Extrahepatic Manifestations of Chronic HBV Infection and the Role of Antiviral Therapy.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 21, p. 6247, doi. 10.3390/jcm11216247
- By:
- Publication type:
- Article
Clonally unrelated Richter syndrome are truly de novo diffuse large B‐cell lymphomas with a mutational profile reminiscent of clonally related Richter syndrome.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 6, p. 1016, doi. 10.1111/bjh.18352
- By:
- Publication type:
- Article
Integrin Signaling Shaping BTK-Inhibitor Resistance.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 14, p. N.PAG, doi. 10.3390/cells11142235
- By:
- Publication type:
- Article
Multiple Mechanisms of NOTCH1 Activation in Chronic Lymphocytic Leukemia: NOTCH1 Mutations and Beyond.
- Published in:
- Cancers, 2022, v. 14, n. 12, p. 2997, doi. 10.3390/cancers14122997
- By:
- Publication type:
- Article
Case Report: Sequential Development of Three Mature Lymphoid Neoplasms in a Single Patient: Clonal Relationship and Molecular Insights.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.917115
- By:
- Publication type:
- Article
Long‐term follow‐up of 415 patients with chronic lymphocytic leukemia treated with fludarabine and cyclophosphamide‐based chemoimmunotherapy in the frontline ADMIRE and ARCTIC trials: A comprehensive assessment of prognostic factors.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 5, p. E168, doi. 10.1002/ajh.26483
- By:
- Publication type:
- Article
5-Azacytidine Downregulates the Proliferation and Migration of Hepatocellular Carcinoma Cells In Vitro and In Vivo by Targeting miR-139-5p/ROCK2 Pathway.
- Published in:
- Cancers, 2022, v. 14, n. 7, p. 1630, doi. 10.3390/cancers14071630
- By:
- Publication type:
- Article
Elastin MIcrofibriL INterfacer1 (EMILIN‐1) is an alternative prosurvival VLA‐4 ligand in chronic lymphocytic leukemia.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 2, p. 181, doi. 10.1002/hon.2947
- By:
- Publication type:
- Article
COVID‐19 vaccination: Evaluation of risk for protection failure in chronic lymphocytic leukemia patients.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 5, p. 712, doi. 10.1002/hon.2916
- By:
- Publication type:
- Article
Hepatitis C virus‐associated indolent B‐cell lymphomas: A review on the role of the new direct antiviral agents therapy.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 4, p. 439, doi. 10.1002/hon.2862
- By:
- Publication type:
- Article
Hepatitis B Virus-Related Cryoglobulinemic Vasculitis: Review of the Literature and Long-Term Follow-Up Analysis of 18 Patients Treated with Nucleos(t)ide Analogues from the Italian Study Group of Cryoglobulinemia (GISC).
- Published in:
- Viruses (1999-4915), 2021, v. 13, n. 6, p. 1032, doi. 10.3390/v13061032
- By:
- Publication type:
- Article
Hepatitis C virus-related cryoglobulinemic vasculitis.
- Published in:
- Minerva Medica, 2021, v. 112, n. 2, p. 175, doi. 10.23736/S0026-4806.20.07120-7
- By:
- Publication type:
- Article
Hepatitis C virus-associated non-Hodgkin lymphomas: the endless history.
- Published in:
- Minerva Medica, 2021, v. 112, n. 2, p. 215, doi. 10.23736/S0026-4806.20.07184-0
- By:
- Publication type:
- Article
Antitumor Effects of PRIMA-1 and PRIMA-1 Met (APR246) in Hematological Malignancies: Still a Mutant P53-Dependent Affair?
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 1, p. 98, doi. 10.3390/cells10010098
- By:
- Publication type:
- Article
Direct‐acting antiviral agents for hepatitis C virus‐mixed cryoglobulinaemia: dissociated virological and haematological responses.
- Published in:
- British Journal of Haematology, 2020, v. 191, n. 5, p. 775, doi. 10.1111/bjh.17036
- By:
- Publication type:
- Article
Immunoglobulin kappa deleting element rearrangements are candidate targets for minimal residual disease evaluation in mantle cell lymphoma.
- Published in:
- Hematological Oncology, 2020, v. 38, n. 5, p. 698, doi. 10.1002/hon.2792
- By:
- Publication type:
- Article
Heterogeneity of TP53 Mutations and P53 Protein Residual Function in Cancer: Does It Matter?
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.593383
- By:
- Publication type:
- Article
An Updated Perspective on Current Prognostic and Predictive Biomarkers in Chronic Lymphocytic Leukemia in the Context of Chemoimmunotherapy and Novel Targeted Therapy.
- Published in:
- Cancers, 2020, v. 12, n. 4, p. 894, doi. 10.3390/cancers12040894
- By:
- Publication type:
- Article
VLA-4 Expression and Activation in B Cell Malignancies: Functional and Clinical Aspects.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 6, p. 2206, doi. 10.3390/ijms21062206
- By:
- Publication type:
- Article
Systemic mastocytosis associated with myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis: Report of three cases.
- Published in:
- 2019
- By:
- Publication type:
- case study
Minimal residual disease (MRD) in non-Hodgkin lymphomas: Interlaboratory reproducibility on marrow samples with very low levels of disease within the FIL (Fondazione Italiana Linfomi) MRD Network.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Transcriptomics and Immunological Analyses Reveal a Pro-Angiogenic and Anti-Inflammatory Phenotype for Decidual Endothelial Cells.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 7, p. 1604, doi. 10.3390/ijms20071604
- By:
- Publication type:
- Article
Regulation of HIF-1 α in TP53 Disrupted Chronic Lymphocytic Leukemia Cells and Its Potential Role as a Therapeutic Target.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S214, doi. 10.1016/j.clml.2018.07.076
- By:
- Publication type:
- Article
Splenic marginal zone lymphomas in acquired C1-inhibitor deficiency: clinical and molecular characterization.
- Published in:
- 2018
- By:
- Publication type:
- journal article
NOTCH1 mutational status in chronic lymphocytic leukaemia: clinical relevance of subclonal mutations and mutation types.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 4, p. 597, doi. 10.1111/bjh.14843
- By:
- Publication type:
- Article
Survival and Prognostic Factors in Mixed Cryoglobulinemia: Data from 246 Cases.
- Published in:
- Diseases, 2018, v. 6, n. 2, p. 35, doi. 10.3390/diseases6020035
- By:
- Publication type:
- Article
Low-dose radiotherapy in diffuse large B-cell lymphoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The BET Bromodomain Inhibitor (BETi) OTX015 (MK-8628) Upregulates miR-96-5p in Diffuse Large B-Cell Lymphomas (DLBCL).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2016, v. 16, p. S105, doi. 10.1016/j.clml.2016.07.151
- By:
- Publication type:
- Article
A new approach for the treatment of CLL using chlorambucil/hydroxychloroquine-loaded anti-CD20 nanoparticles.
- Published in:
- Nano Research, 2016, v. 9, n. 2, p. 537, doi. 10.1007/s12274-015-0935-3
- By:
- Publication type:
- Article
Multiple myeloma: New surface antigens for the characterization of plasma cells in the era of novel agents.
- Published in:
- Cytometry. Part B, 2016, v. 90, n. 1, p. 81, doi. 10.1002/cyto.b.21279
- By:
- Publication type:
- Article
CD18 (ITGB2) expression in chronic lymphocytic leukaemia is regulated by DNA methylation-dependent and -independent mechanisms.
- Published in:
- British Journal of Haematology, 2015, v. 169, n. 2, p. 286, doi. 10.1111/bjh.13188
- By:
- Publication type:
- Article
Recombinant Human Erythropoietin (RHuEpo) and Granular Colony Stimulating Factor (G-CSF) in hepatitis C virus (HCV) related to mixed cryoglobulinaemia associated to membranoproliferative glomerulonephritis type I: a case report description.
- Published in:
- Infezioni in Medicina, 2014, v. 22, n. 4, p. 337
- By:
- Publication type:
- Article
Potential therapeutic role of antagomiR17 for the treatment of chronic lymphocytic leukemia.
- Published in:
- Journal of Hematology & Oncology, 2014, v. 7, n. 1, p. 1, doi. 10.1186/s13045-014-0079-z
- By:
- Publication type:
- Article
NOTCH1 mutations identify a chronic lymphocytic leukemia patient subset with worse prognosis in the setting of a rituximab-based induction and consolidation treatment.
- Published in:
- Annals of Hematology, 2014, v. 93, n. 10, p. 1765, doi. 10.1007/s00277-014-2117-x
- By:
- Publication type:
- Article
Endothelin-1 Promotes Survival and Chemoresistance in Chronic Lymphocytic Leukemia B Cells through ET<sub>A</sub> Receptor.
- Published in:
- PLoS ONE, 2014, v. 9, n. 6, p. 1, doi. 10.1371/journal.pone.0098818
- By:
- Publication type:
- Article
Detection of TP53 dysfunction in chronic lymphocytic leukemia by an in vitro functional assay based on TP53 activation by the non-genotoxic drug Nutlin-3: a proposal for clinical application.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 3, doi. 10.1186/1756-8722-6-83
- By:
- Publication type:
- Article
Promoter methylation patterns in Richter syndrome affect stem-cell maintenance and cell cycle regulation and differ from de novo diffuse large B-cell lymphoma.
- Published in:
- British Journal of Haematology, 2013, v. 163, n. 2, p. 194, doi. 10.1111/bjh.12515
- By:
- Publication type:
- Article
New Potential Therapeutic Approach for the Treatment of B-Cell Malignancies Using Chlorambucil/Hydroxychloroquine-Loaded Anti-CD20 Nanoparticles.
- Published in:
- PLoS ONE, 2013, v. 8, n. 9, p. 1, doi. 10.1371/journal.pone.0074216
- By:
- Publication type:
- Article
Clinical heterogeneity of de novo 11q deletion chronic lymphocytic leukaemia: prognostic relevance of extent of 11q deleted nuclei inside leukemic clone.
- Published in:
- Hematological Oncology, 2013, v. 31, n. 2, p. 348, doi. 10.1002/hon.2028
- By:
- Publication type:
- Article
ARHGDIA, a mutant TP53-associated Rho GDP dissociation inhibitor, is over-expressed in gene expression profiles of TP53 disrupted chronic lymphocytic leukaemia cells.
- Published in:
- British Journal of Haematology, 2013, v. 161, n. 4, p. 596, doi. 10.1111/bjh.12258
- By:
- Publication type:
- Article
Clinical significance of c.7544-7545 del CT NOTCH1 mutation in chronic lymphocytic leukaemia.
- Published in:
- British Journal of Haematology, 2013, v. 160, n. 3, p. 415, doi. 10.1111/bjh.12128
- By:
- Publication type:
- Article
Molecular history of Richter syndrome: origin from a cell already present at the time of chronic lymphocytic leukemia diagnosis.
- Published in:
- International Journal of Cancer, 2012, v. 130, n. 12, p. 3006, doi. 10.1002/ijc.26322
- By:
- Publication type:
- Article
Del(13q14.3) length matters: an integrated analysis of genomic, fluorescence in situ hybridization and clinical data in 169 chronic lymphocytic leukaemia patients with 13q deletion alone or a normal karyotype.
- Published in:
- Hematological Oncology, 2012, v. 30, n. 1, p. 46, doi. 10.1002/hon.997
- By:
- Publication type:
- Article